查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1877394

疫苗管理解決方案市場：按應用、類型、解決方案類型、部署模式、最終用戶、疫苗類型、國家/地區分類 - 全球產業分析、市場規模、市場佔有率及2025-2032年預測

Vaccine Management Solution Market, By Application, By Type, By Solution Type, By Deployment mode, By End-user, By Vaccine Type, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 399 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年疫苗管理解決方案市場規模為 25.7845 億美元，從 2025 年到 2032 年將以 13.2% 的複合年成長率成長。

疫苗管理解決方案是簡化疫苗管理和接種流程的數位化平台。這些解決方案可幫助醫療機構追蹤疫苗庫存水準、劑量可用性、有效期限和儲存條件。它們也幫助州和地方政府安全快速地進行疫苗接種工作。多家公司利用這些解決方案追蹤員工的疫苗接種情況。疫苗可預防疾病在全球範圍內的日益流行，使得可靠的疫苗管理系統顯得格外重要。政府的疫苗接種活動和對數位醫療基礎設施的投資正在推動市場成長。然而，嚴格的疫苗儲存和分發法規也給市場參與者帶來了挑戰。由於基礎設施先進且醫療保健支出較高，北美地區的市場滲透率最高。憑藉快速的疫苗研發、不斷提升的產能和頻繁的法規核准，美國繼續在全球疫苗管理解決方案市場佔據主導地位。

疫苗管理解決方案市場—市場動態

全球免疫計劃的不斷發展將促進市場成長

國家和全球免疫規劃的快速擴張是疫苗管理解決方案市場的重要驅動力。各國政府和衛生組織正日益轉向數位化疫苗管理平台，以確保疫苗的高效分發、即時追蹤和公平取得。這些解決方案有助於監控冷鏈物流、減少浪費並提高疫苗交付系統的透明度。例如，世界衛生組織（世衛組織）估計，到2023年，全球疫苗接種覆蓋率將達到84%，屆時將有超過44億人透過各種免疫規劃接種至少一劑疫苗。疫苗接種規模的不斷擴大增加了對先進數位化管理系統的需求，促使醫療機構和政府投資於自動化、基於雲端的疫苗管理解決方案，以最佳化營運並確保供應的完整性。

疫苗管理解決方案市場區隔分析：

全球疫苗管理解決方案市場按應用程式、類型、解決方案類型、部署模式、最終用戶、疫苗類型和地區進行細分。

平台解決方案和單點解決方案是兩種主要類型。預計到2025年，平台解決方案將佔據顯著的市場佔有率。此細分市場的成長主要歸功於主要市場參與者之間為支持新冠疫苗分發而加強的合作。例如，2020年11月，Infosys有限公司與軟體開發公司Salesforce合作，基於Salesforce平台開發了疫苗管理雲端解決方案，以協助聯邦政府分發新冠疫苗。

根據解決方案類型：由於其強大的資料控制能力、靈活的客製化能力以及對機構安全協議的合規性，本地部署仍然是疫苗管理解決方案市場中最受歡迎的模式。醫院、政府機構和製藥公司經常使用當地部署系統來管理必須遵守嚴格監管框架的敏感病患和免疫記錄。例如，馬爾地夫將於2022年10月推出其全國電子免疫登記系統（EIR），該系統基於該國自身的DHIS2基礎設施，並在世界衛生組織的支持下運作。透過內部託管該系統，衛生部保留了對資料存取、儲存和安全設定的完全控制權。這些案例凸顯了為何本地部署解決方案仍然佔據主導地位，尤其是在那些優先考慮資料主權或雲端基礎架構有限的地區。

疫苗管理解決方案市場—地理洞察

預計到2023年，北美將在全球疫苗管理解決方案市場佔據相當大的佔有率。為控制肝炎、結核病、人類乳突病毒（HPV）等多種疾病的傳播，疫苗接種活動的需求不斷成長，這推動了該地區市場的成長。例如，根據美國國家生物技術資訊中心（NCBI）2023年3月發布的一項研究，2022年美國報告了8,300例結核病病例。此外，疫苗管理解決方案的日益普及，以及對疫苗接種流程和供應鏈管理的支持，預計也將推動市場擴張。

美國疫苗管理解決方案市場—國家概況

由於疫苗研發的快速進展、產能的提升以及法規核准的頻繁，美國在全球疫苗管理解決方案市場持續創造可觀的收入。疫苗製劑（尤其是流感疫苗和兒童疫苗）數量的不斷成長，使得高效的數位化平台對於庫存追蹤、分發和冷鏈監控變得至關重要。例如，2022年6月，CSL Seqirus完成了其美國工廠1.56億美元的擴建項目，旨在提升其細胞培養流感疫苗的製劑和填充能力。此外，2021年10月，FDA批准了Seqirus的四價流感疫苗（FLUCELVAX QUADRIVALENT）擴大適用年齡範圍。這些進展增加了疫苗的產量和分發的複雜性，加速了美國各地對先進疫苗管理解決方案的採用。

疫苗管理解決方案市場—競爭格局：

IBM、甲骨文公司、SAP SE、印孚瑟斯有限公司、微軟公司和德勤會計師事務所是疫苗管理解決方案領域的市場領導者。這些企業利用雲端運算、區塊鏈和人工智慧驅動的分析技術來提高疫苗的分發、儲存和追蹤效率。物聯網賦能的冷鏈監控系統和數據驅動的庫存管理平台的使用，確保了疫苗供應鏈的透明度和即時可視性。技術提供者、醫療機構和政府機構之間的策略合作正在影響市場成長動態。隨著全球免疫規劃的擴展和數位健康基礎設施的完善，為了滿足日益成長的對高效可靠疫苗管理解決方案的需求，競爭格局的特點是資料安全、可擴展性和互通性方面的創新。

目錄

第1章：疫苗管理解決方案市場概覽

  • 研究範圍
  • 市場估算年份

第2章：執行概要

  • 市集
    • 疫苗管理解決方案市場概覽（按應用領域分類）
    • 疫苗管理解決方案市場概覽（按類型分類）
    • 疫苗管理解決方案市場概覽（按解決方案類型分類）
    • 疫苗管理解決方案市場概覽（按部署模式分類）
    • 疫苗管理解決方案市場按最終用戶分類的概覽
    • 疫苗管理解決方案市場概覽（按疫苗類型分類）
    • 各國疫苗管理解決方案市場概覽
    • 疫苗管理解決方案市場概覽（按地區分類）
  • 競爭洞察

第3章：疫苗管理解決方案的關鍵市場趨勢

  • 疫苗管理解決方案市場促進因素
    • 市場促進因素的影響分析
  • 疫苗管理解決方案市場限制因素
    • 市場限制因素的影響分析
  • 疫苗管理解決方案市場機遇
  • 疫苗管理解決方案市場未來趨勢

第4章：疫苗管理解決方案產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景分析
  • 規範架構分析

第5章：疫苗管理解決方案市場：地緣政治緊張局勢升級的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：疫苗管理解決方案市場概況

  • 疫苗管理解決方案市佔率分析，2024 年
  • 主要製造商細分數據
    • 知名球員分析
    • 新興參與者分析

第7章：疫苗管理解決方案市場－按應用領域分類

  • 概述
    • 按應用領域分類的細分市場佔有率分析
    • 供應鏈管理
    • 庫存管理
    • 行政和檔案管理
    • 結果監測
    • 組織支持
    • 病人登記及預約
    • 其他

第8章：疫苗管理解決方案市場－按類型分類

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 平台解決方案
    • 一點解決方案

第9章：疫苗管理解決方案市場－按解決方案類型分類

  • 概述
    • 按解決方案類型分類的細分市場佔有率分析
    • 本地部署
    • 基於雲端的
    • 混合

第10章：疫苗管理解決方案市場－以部署模式分類

  • 概述
    • 按部署模式分類的細分市場佔有率分析
    • SaaS
    • 基礎設施即服務 (IaaS)
    • PaaS
    • 自託管

第11章：疫苗管理解決方案市場－以最終用戶分類

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院和診所
    • 政府設施
    • 企業組織
    • 其他

第12章：疫苗管理解決方案市場－按疫苗類型分類

  • 概述
    • 按疫苗類型分類的細分市場佔有率分析
    • 活疫苗
    • 去活化疫苗
    • 結合疫苗
    • 類毒素疫苗
    • 亞單位疫苗

第13章：疫苗管理解決方案市場－依地理分類

  • 介紹
    • 按地域分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美疫苗管理解決方案主要製造商
    • 北美市場規模及預測（按國家/地區分類）
    • 北美市場規模及預測（按應用分類）
    • 北美市場規模及預測（按類型分類）
    • 北美市場規模及預測（按解決方案類型分類）
    • 北美市場規模及預測（依部署模式分類）
    • 北美市場規模及預測（依最終用戶分類）
    • 北美洲疫苗市場規模及預測
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲疫苗管理解決方案主要製造商
    • 歐洲市場規模及預測（按國家/地區分類）
    • 歐洲市場規模及預測（按應用領域分類）
    • 歐洲市場規模及預測（按類型分類）
    • 歐洲市場規模及預測（按解決方案類型分類）
    • 歐洲市場規模及預測（依部署模式分類）
    • 歐洲市場規模及預測（依最終用戶分類）
    • 歐洲疫苗市場規模及預測（依疫苗類型分類）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區
    • 概述
    • 亞太地區疫苗管理解決方案主要製造商
    • 亞太市場規模及預測（依國家/地區分類）
    • 亞太市場規模及預測（按應用分類）
    • 亞太市場規模及預測（按類型分類）
    • 亞太市場規模及預測（按解決方案類型分類）
    • 亞太地區市場規模及預測（依部署模式分類）
    • 亞太市場規模及預測（依最終用戶分類）
    • 亞太地區疫苗市場規模及預測（依疫苗類型分類）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲疫苗管理解決方案主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區分類）
    • 拉丁美洲市場規模及預測（按應用分類）
    • 拉丁美洲市場規模及預測（按類型分類）
    • 拉丁美洲市場規模及預測（按解決方案類型分類）
    • 拉丁美洲市場規模及預測（按部署模式分類）
    • 拉丁美洲規模及預測（按最終用戶分類）
    • 拉丁美洲疫苗市場規模及預測
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲疫苗管理解決方案主要製造商
    • 中東和非洲市場規模及預測（按國家/地區分類）
    • 中東和非洲市場規模及預測（按應用分類）
    • 中東和非洲市場規模及預測（按類型分類）
    • 中東和非洲市場規模及預測（按解決方案類型分類）
    • 中東和非洲市場規模及預測（按部署模式分類）
    • 中東和非洲市場規模及預測（按最終用戶分類）
    • 中東和非洲疫苗市場規模及預測（按疫苗類型分類）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 中東和非洲其他地區

第14章：主要供應商分析－疫苗管理解決方案產業

  • 競爭基準化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司簡介
    • IBM Corporation
    • Siemens Healthineers
    • Accenture
    • SAP SE
    • Oracle Corporation
    • Infosys Limited
    • SoftClinic
    • Logistimo Technologies
    • OmniSYS
    • VaxCare Digital Health
    • Helix Software
    • Blue Vector
    • Andor Health
    • STChealth
    • eHealth Africa
    • Others

第15章：360度分析師視角

第16章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5760

Vaccine Management Solution Market size was valued at US$ 2,578.45 Million in 2024, expanding at a CAGR of 13.2% from 2025 to 2032.

Vaccine management solutions are digital platforms that simplify the process of managing and administering vaccines. Vaccine management solutions help healthcare providers track vaccine inventory levels, dose availability, expiration dates, and storage conditions. These solutions help state and local governments administer vaccinations safely and quickly. Several companies use this solution to track employee vaccinations. The increasing global prevalence of vaccine-preventable diseases requires reliable vaccine management systems. Government vaccination campaigns and digital health infrastructure investments are driving market growth. However, strict vaccine storage and distribution regulations challenge market participants. Market penetration is highest in North America due to advanced infrastructure and higher healthcare spending. Due to rapid vaccine R&D, increased production capacity, and frequent regulatory approvals, the US continues to dominate the global Vaccine Management Solution Market.

Vaccine Management Solution Market- Market Dynamics

Growing Global Immunization Programs to Boost Market Growth

The rapid expansion of national and global immunization programs is a significant driver of the Vaccine Management Solution Market. Governments and health organizations are increasingly turning to digital vaccine management platforms to ensure efficient distribution, real-time tracking, and equitable access to vaccines. These solutions help to monitor cold chain logistics, reduce waste, and improve vaccine delivery system transparency. For instance, the World Health Organization (WHO) estimates that global vaccination coverage will reach 84% by 2023, with over 4.4 billion people receiving at least one vaccine dose through various immunization programs. The growing scale of vaccination initiatives has increased the demand for advanced digital management systems, encouraging healthcare providers and governments to invest in automated, cloud-based vaccine management solutions to optimise operations and ensure supply integrity.

Vaccine Management Solution Market- Segmentation Analysis:

The Global Vaccine Management Solution Market is segmented on the basis of Application, Type, Solution Type, Deployment mode, End-user, Vaccine Type, and Region.

Platform solutions and one-point solutions are the two types. In 2025, the platform solutions segment holds a significant market share. The segment's growth is attributed to increased collaborations among key market players to support the distribution of COVID-19 vaccines. For example, in November 2020, Infosys Limited and Salesforce, a software development company, collaborated to develop a vaccine management cloud solution based on the Salesforce platform to assist the federal government in the distribution of coronavirus vaccines.

Based on Solution type: On-premise deployment remains the most preferred model in the vaccine management solution market due to its strong data control, customization flexibility, and compliance with institutional security protocols. On-premise systems are frequently used by hospitals, government agencies, and pharmaceutical companies to manage sensitive patient and immunization records that must adhere to strict regulatory frameworks. For instance, in October 2022, the Maldives will launch its nationwide Electronic Immunization Registry (EIR), based on the country's own DHIS2 infrastructure and with World Health Organization support. By hosting the system internally, the Ministry of Health retained complete control over data access, storage, and security settings. Such examples highlight why on-premise solutions remain dominant, particularly in regions that prioritize data sovereignty or operate with limited cloud infrastructure.

Vaccine Management Solution Market- Geographical Insights

North America is expected to hold a sizable share of the global vaccine management solutions market in 2023. The increased need for vaccination campaigns to control the spread of various diseases, such as hepatitis, tuberculosis, human papillomavirus (HPV), and others, is driving regional growth. For instance, according to a study published in March 2023 by the National Centre for Biotechnology Information (NCBI), 8,300 tuberculosis cases were reported in the United States in 2022. Furthermore, an increase in the introduction of vaccine management solutions to support the vaccination process and supply chain management is expected to drive market expansion.

United States Vaccine Management Solution Market- Country Insights

The United States continues to generate significant revenue in the global Vaccine Management Solution Market, owing to rapid advances in vaccine R&D, increased production capacity, and frequent regulatory approvals. The increasing volume of vaccine formulations, particularly influenza and pediatric vaccines, necessitates efficient digital platforms for inventory tracking, distribution, and cold-chain monitoring. For instance, in June 2022, CSL Seqirus completed a USD 156 million expansion of its US facility to improve formulation and fill-finish capabilities for its cell-based influenza vaccines. Furthermore, in October 2021, the FDA approved Seqirus' FLUCELVAX QUADRIVALENT for an extended age range. Such developments increase vaccine output and distribution complexity, hastening the adoption of advanced vaccine management solutions throughout the country.

Vaccine Management Solution Market- Competitive Landscape:

IBM, Oracle Corporation, SAP SE, Infosys Limited, Microsoft Corporation, and Deloitte Touche Tohmatsu Limited are among the market leaders in vaccine management solutions. These businesses use cloud computing, blockchain, and AI-powered analytics to improve vaccine distribution, storage, and tracking efficiency. The use of IoT-enabled cold chain monitoring systems and data-driven inventory management platforms ensures transparency and real-time visibility throughout the vaccine supply chain. Strategic collaborations among technology providers, healthcare organizations, and government agencies are influencing market growth dynamics. As global immunization programmes expand and digital health infrastructures improve, the competitive landscape is characterized by innovation in data security, scalability, and interoperability to meet the growing demand for efficient and dependable vaccine management solutions.

Recent Developments:

In May 2024, Novavax and Sanofi entered into a co-exclusive licensing agreement to jointly commercialize a COVID-19 vaccine and collaborate on the development of novel COVID-19 and influenza vaccine combinations.

In April 2023, Pfizer disclosed results from phase 3 trials of its RSV vaccines. The study of adult patients found that the vaccine was 67% more effective in preventing infections with two associated symptoms and 86% effective in cases of severe disease.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL VACCINE MANAGEMENT SOLUTION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • IBM Corporation
  • Siemens Healthineers
  • Accenture
  • SAP SE
  • Oracle Corporation
  • Infosys Limited
  • SoftClinic
  • Logistimo Technologies
  • OmniSYS
  • VaxCare Digital Health
  • Helix Software
  • Blue Vector
  • Andor Health
  • STChealth
  • eHealth Africa
  • Others

GLOBAL VACCINE MANAGEMENT SOLUTION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Supply Chain Management
  • Inventory Management
  • Administration and Record Management
  • Outcome Monitoring
  • Organizational Support
  • Patient Registration and Scheduling
  • Others

GLOBAL VACCINE MANAGEMENT SOLUTION MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Platform Solutions
  • One Point Solutions

GLOBAL VACCINE MANAGEMENT SOLUTION MARKET, BY SOLUTION TYPE- MARKET ANALYSIS, 2019 - 2032

  • On-premise
  • Cloud-based
  • Hybrid

GLOBAL VACCINE MANAGEMENT SOLUTION MARKET, BY DEPLOYMENT MODE- MARKET ANALYSIS, 2019 - 2032

  • SaaS
  • IaaS
  • PaaS
  • Self-hosted

GLOBAL VACCINE MANAGEMENT SOLUTION MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Government Facilities
  • Corporate Organizations
  • Others

GLOBAL VACCINE MANAGEMENT SOLUTION MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Live vaccines
  • Inactivated vaccines
  • Conjugate vaccines
  • Toxoid vaccines
  • Subunit vaccines

GLOBAL VACCINE MANAGEMENT SOLUTION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Vaccine Management Solution Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Vaccine Management Solution Market Snippet by Application
    • 2.1.2. Vaccine Management Solution Market Snippet by Type
    • 2.1.3. Vaccine Management Solution Market Snippet by Solution Type
    • 2.1.4. Vaccine Management Solution Market Snippet by Deployment mode
    • 2.1.5. Vaccine Management Solution Market Snippet by End-user
    • 2.1.6. Vaccine Management Solution Market Snippet by Vaccine Type
    • 2.1.7. Vaccine Management Solution Market Snippet by Country
    • 2.1.8. Vaccine Management Solution Market Snippet by Region
  • 2.2. Competitive Insights

3. Vaccine Management Solution Key Market Trends

  • 3.1. Vaccine Management Solution Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Vaccine Management Solution Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Vaccine Management Solution Market Opportunities
  • 3.4. Vaccine Management Solution Market Future Trends

4. Vaccine Management Solution Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Vaccine Management Solution Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Vaccine Management Solution Market Landscape

  • 6.1. Vaccine Management Solution Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Vaccine Management Solution Market - By Application

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 7.1.2. Supply Chain Management
    • 7.1.3. Inventory Management
    • 7.1.4. Administration and Record Management
    • 7.1.5. Outcome Monitoring
    • 7.1.6. Organizational Support
    • 7.1.7. Patient Registration and Scheduling
    • 7.1.8. Others

8. Vaccine Management Solution Market - By Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 8.1.2. Platform Solutions
    • 8.1.3. One Point Solutions

9. Vaccine Management Solution Market - By Solution Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Solution Type, 2024 & 2032 (%)
    • 9.1.2. On-premise
    • 9.1.3. Cloud-based
    • 9.1.4. Hybrid

10. Vaccine Management Solution Market - By Deployment mode

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Deployment mode, 2024 & 2032 (%)
    • 10.1.2. SaaS
    • 10.1.3. IaaS
    • 10.1.4. PaaS
    • 10.1.5. Self-hosted

11. Vaccine Management Solution Market - By End-user

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 11.1.2. Hospitals & Clinics
    • 11.1.3. Government Facilities
    • 11.1.4. Corporate Organizations
    • 11.1.5. Others

12. Vaccine Management Solution Market - By Vaccine Type

  • 12.1. Overview
    • 12.1.1. Segment Share Analysis, By Vaccine Type, 2024 & 2032 (%)
    • 12.1.2. Live vaccines
    • 12.1.3. Inactivated vaccines
    • 12.1.4. Conjugate vaccines
    • 12.1.5. Toxoid vaccines
    • 12.1.6. Subunit vaccines

13. Vaccine Management Solution Market- By Geography

  • 13.1. Introduction
    • 13.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 13.2. North America
    • 13.2.1. Overview
    • 13.2.2. Vaccine Management Solution Key Manufacturers in North America
    • 13.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.2.4. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 13.2.6. North America Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 13.2.7. North America Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
    • 13.2.8. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 13.2.9. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.2.10. U.S.
      • 13.2.10.1. Overview
      • 13.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.2.10.3. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.2.10.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.2.10.5. U.S. Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.2.10.6. U.S. Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.2.10.7. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.2.10.8. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.2.11. Canada
      • 13.2.11.1. Overview
      • 13.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.2.11.3. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.2.11.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.2.11.5. Canada Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.2.11.6. Canada Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.2.11.7. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.2.11.8. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  • 13.3. Europe
    • 13.3.1. Overview
    • 13.3.2. Vaccine Management Solution Key Manufacturers in Europe
    • 13.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.3.4. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 13.3.6. Europe Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 13.3.7. Europe Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
    • 13.3.8. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 13.3.9. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.3.10. Germany
      • 13.3.10.1. Overview
      • 13.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.10.3. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.10.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.3.10.5. Germany Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.3.10.6. Germany Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.3.10.7. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.3.10.8. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.3.11. UK
      • 13.3.11.1. Overview
      • 13.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.11.3. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.11.4. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.3.11.5. UK Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.3.11.6. UK Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.3.11.7. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.3.11.8. UK Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.3.12. France
      • 13.3.12.1. Overview
      • 13.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.12.3. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.12.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.3.12.5. France Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.3.12.6. France Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.3.12.7. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.3.12.8. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.3.13. Italy
      • 13.3.13.1. Overview
      • 13.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.13.3. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.13.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.3.13.5. Italy Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.3.13.6. Italy Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.3.13.7. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.3.13.8. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.3.14. Spain
      • 13.3.14.1. Overview
      • 13.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.14.3. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.14.4. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.3.14.5. Spain Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.3.14.6. Spain Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.3.14.7. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.3.14.8. Spain Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.3.15. The Netherlands
      • 13.3.15.1. Overview
      • 13.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.15.3. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.15.4. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.3.15.5. The Netherlands Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.3.15.6. The Netherlands Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.3.15.7. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.3.15.8. The Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.3.16. Sweden
      • 13.3.16.1. Overview
      • 13.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.16.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.16.4. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.3.16.5. Sweden Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.3.16.6. Sweden Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.3.16.7. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.3.16.8. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.3.17. Russia
      • 13.3.17.1. Overview
      • 13.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.17.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.17.4. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.3.17.5. Russia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.3.17.6. Russia Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.3.17.7. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.3.17.8. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.3.18. Poland
      • 13.3.18.1. Overview
      • 13.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.18.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.18.4. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.3.18.5. Poland Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.3.18.6. Poland Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.3.18.7. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.3.18.8. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.3.19. Rest of Europe
      • 13.3.19.1. Overview
      • 13.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.19.3. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.19.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.3.19.5. Rest of the Europe Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.3.19.6. Rest of the Europe Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.3.19.7. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.3.19.8. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  • 13.4. Asia Pacific (APAC)
    • 13.4.1. Overview
    • 13.4.2. Vaccine Management Solution Key Manufacturers in Asia Pacific
    • 13.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.4.4. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.4.5. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 13.4.6. APAC Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 13.4.7. APAC Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
    • 13.4.8. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 13.4.9. APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.4.10. China
      • 13.4.10.1. Overview
      • 13.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.10.3. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.10.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.4.10.5. China Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.4.10.6. China Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.4.10.7. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.4.10.8. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.4.11. India
      • 13.4.11.1. Overview
      • 13.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.11.3. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.11.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.4.11.5. India Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.4.11.6. India Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.4.11.7. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.4.11.8. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.4.12. Japan
      • 13.4.12.1. Overview
      • 13.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.12.3. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.12.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.4.12.5. Japan Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.4.12.6. Japan Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.4.12.7. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.4.12.8. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.4.13. South Korea
      • 13.4.13.1. Overview
      • 13.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.13.3. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.13.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.4.13.5. South Korea Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.4.13.6. South Korea Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.4.13.7. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.4.13.8. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.4.14. Australia
      • 13.4.14.1. Overview
      • 13.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.14.3. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.14.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.4.14.5. Australia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.4.14.6. Australia Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.4.14.7. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.4.14.8. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.4.15. Indonesia
      • 13.4.15.1. Overview
      • 13.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.15.3. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.15.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.4.15.5. Indonesia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.4.15.6. Indonesia Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.4.15.7. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.4.15.8. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.4.16. Thailand
      • 13.4.16.1. Overview
      • 13.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.16.3. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.16.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.4.16.5. Thailand Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.4.16.6. Thailand Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.4.16.7. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.4.16.8. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.4.17. Philippines
      • 13.4.17.1. Overview
      • 13.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.17.3. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.17.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.4.17.5. Philippines Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.4.17.6. Philippines Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.4.17.7. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.4.17.8. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.4.18. Rest of APAC
      • 13.4.18.1. Overview
      • 13.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.18.3. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.18.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.4.18.5. Rest of APAC Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.4.18.6. Rest of APAC Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.4.18.7. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.4.18.8. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  • 13.5. Latin America (LATAM)
    • 13.5.1. Overview
    • 13.5.2. Vaccine Management Solution Key Manufacturers in Latin America
    • 13.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.5.4. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.5.5. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 13.5.6. LATAM Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 13.5.7. LATAM Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
    • 13.5.8. LATAM Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 13.5.9. LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.5.10. Brazil
      • 13.5.10.1. Overview
      • 13.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.10.3. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.10.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.5.10.5. Brazil Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.5.10.6. Brazil Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.5.10.7. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.5.10.8. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.5.11. Mexico
      • 13.5.11.1. Overview
      • 13.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.11.3. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.11.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.5.11.5. Mexico Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.5.11.6. Mexico Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.5.11.7. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.5.11.8. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.5.12. Argentina
      • 13.5.12.1. Overview
      • 13.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.12.3. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.12.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.5.12.5. Argentina Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.5.12.6. Argentina Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.5.12.7. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.5.12.8. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.5.13. Colombia
      • 13.5.13.1. Overview
      • 13.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.13.3. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.13.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.5.13.5. Colombia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.5.13.6. Colombia Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.5.13.7. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.5.13.8. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.5.14. Rest of LATAM
      • 13.5.14.1. Overview
      • 13.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.14.3. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.14.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.5.14.5. Rest of LATAM Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.5.14.6. Rest of LATAM Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.5.14.7. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.5.14.8. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  • 13.6. Middle East and Africa
    • 13.6.1. Overview
    • 13.6.2. Vaccine Management Solution Key Manufacturers in Middle East and Africa
    • 13.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.6.4. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.6.5. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 13.6.6. Middle East and Africa Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 13.6.7. Middle East and Africa Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
    • 13.6.8. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 13.6.9. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.6.10. Saudi Arabia
      • 13.6.10.1. Overview
      • 13.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.10.3. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.10.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.6.10.5. Saudi Arabia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.6.10.6. Saudi Arabia Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.6.10.7. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.6.10.8. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.6.11. United Arab Emirates
      • 13.6.11.1. Overview
      • 13.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.11.3. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.11.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.6.11.5. United Arab Emirates Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.6.11.6. United Arab Emirates Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.6.11.7. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.6.11.8. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.6.12. Israel
      • 13.6.12.1. Overview
      • 13.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.12.3. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.12.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.6.12.5. Israel Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.6.12.6. Israel Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.6.12.7. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.6.12.8. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.6.13. Turkey
      • 13.6.13.1. Overview
      • 13.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.13.3. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.13.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.6.13.5. Turkey Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.6.13.6. Turkey Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.6.13.7. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.6.13.8. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.6.14. Algeria
      • 13.6.14.1. Overview
      • 13.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.14.3. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.14.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.6.14.5. Algeria Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.6.14.6. Algeria Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.6.14.7. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.6.14.8. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.6.15. Egypt
      • 13.6.15.1. Overview
      • 13.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.15.3. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.15.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.6.15.5. Egypt Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.6.15.6. Egypt Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.6.15.7. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.6.15.8. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 13.6.16. Rest of MEA
      • 13.6.16.1. Overview
      • 13.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.16.3. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.16.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 13.6.16.5. Rest of MEA Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 13.6.16.6. Rest of MEA Market Size and Forecast, By Deployment mode, 2019 - 2032 (US$ Million)
      • 13.6.16.7. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
      • 13.6.16.8. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)

14. Key Vendor Analysis- Vaccine Management Solution Industry

  • 14.1. Competitive Benchmarking
    • 14.1.1. Competitive Dashboard
    • 14.1.2. Competitive Positioning
  • 14.2. Company Profiles
    • 14.2.1. IBM Corporation
    • 14.2.2. Siemens Healthineers
    • 14.2.3. Accenture
    • 14.2.4. SAP SE
    • 14.2.5. Oracle Corporation
    • 14.2.6. Infosys Limited
    • 14.2.7. SoftClinic
    • 14.2.8. Logistimo Technologies
    • 14.2.9. OmniSYS
    • 14.2.10. VaxCare Digital Health
    • 14.2.11. Helix Software
    • 14.2.12. Blue Vector
    • 14.2.13. Andor Health
    • 14.2.14. STChealth
    • 14.2.15. eHealth Africa
    • 14.2.16. Others

15. 360 Degree Analyst View

16. Appendix

  • 16.1. Research Methodology
  • 16.2. References
  • 16.3. Abbreviations
  • 16.4. Disclaimer
  • 16.5. Contact Us